#-superbox-section-31-175{padding-top:120px}@media (max-width:767px){#-superbox-section-31-175{padding-top:0px}}#-two-column-content-11-175{oxy-two-column-content-show-buttons:yes;oxy-two-column-content-button1-style:btn-secondary-light;oxy-two-column-content-button-text:Learn Mordgde}#-two-column-content-23-175{margin-bottom:-20px}#-timeline-section-25-175{oxy-timeline-section-items-per-view:5;oxy-timeline-section-show-navigation:yes;oxy-timeline-section-timeline-2-description:Pivoted to medical imaging and rebranded as LunitSecured $0.1M seed funding from Kakao Ventures;oxy-timeline-section-timeline-3-description:Placed 5th in ImageNet ChallengeSecured $2M Series A funding led by SoftBank Ventures Asia;oxy-timeline-section-timeline-4-description:Secured $3.3M Series A1 funding led by SoftBank Ventures AsiaWon 1st place in MICCAI Tumor Proliferation Assessment Challenge;oxy-timeline-section-timeline-5-description:Named among Top 100 AI Startup by CB InsightsRecognized as a Top 5 “Social Impact” AI Startup by NVIDIAWon 1st place in CAMELYON Grand Challenge 2017Placed 5th in the Digital Mammography DREAM ChallengeLaunched first chest Xx-ray product,Lunit INSIGHT CXR-Nodule;oxy-timeline-section-timeline-6-description:Secured $15M Series B funding led by Intervest;oxy-timeline-section-timeline-7-description:Received clearance from Korea’s Ministry of Food and Drug Safety for Lunit INSIGHT CXR-Nodule;oxy-timeline-section-timeline-8-description:Foundation of company (as CLDI);oxy-timeline-section-slug--border-bottom-width:6}